Crescent Capital BDC (CCAP) Financials

Crescent Capital BDC logo
$9.89 -0.19 (-1.92%)
Closing price 03:59 PM Eastern
Extended Trading
$9.88 0.00 (-0.01%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Crescent Capital BDC

Annual Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-20 84 -43 0.26 -16 -32
Consolidated Net Income / (Loss)
55 79 -43 0.26 -16 -32
Net Income / (Loss) Continuing Operations
-20 79 -43 0.26 -16 -32
Total Pre-Tax Income
100 79 -43 0.26 -16 -32
Total Revenue
-15 83 0.00 0.00 0.00 0.00
Net Interest Income / (Expense)
-15 83 0.00 0.00 0.00 0.00
Total Interest Income
0.00 83 0.00 0.00 0.00 0.00
Total Interest Expense
15 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income
0.00 0.79 0.00 0.00 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments
- - 0.00 0.00 0.00 0.00
Total Non-Interest Expense
4.44 4.40 0.00 0.00 0.00 0.00
Nonoperating Income / (Expense), net
- - -43 0.26 -16 -32
Basic Earnings per Share
$1.80 $1.67 $1.93 $2.30 $2.40 $1.81
Weighted Average Basic Shares Outstanding
27.68M 28.48M 30.89M 35.93M 37.06M 37.04M
Diluted Earnings per Share
$1.80 $1.67 $1.93 $2.30 $2.40 $1.81
Weighted Average Diluted Shares Outstanding
27.68M 28.48M 30.89M 35.93M 37.06M 37.04M
Weighted Average Basic & Diluted Shares Outstanding
- - 30.89M 37.06M 37.06M 36.92M

Quarterly Income Statements for Crescent Capital BDC

This table shows Crescent Capital BDC's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
4.35 -6.10 -13 -17 -13 -1.87 -9.83 -0.82 -31 -16 -3.58
Consolidated Net Income / (Loss)
4.35 -6.10 -13 -17 -13 -1.87 -9.83 -0.82 -31 -16 -3.58
Net Income / (Loss) Continuing Operations
4.35 -6.10 -13 -17 -13 -1.87 -9.83 -0.82 -31 -16 -3.58
Total Pre-Tax Income
4.35 -6.10 -13 -17 -13 -1.87 -9.83 -0.82 -31 -16 -3.58
Total Revenue
0.00 0.00 0.00 -6.44 0.00 0.00 0.00 - 0.00 0.00 0.00
Net Interest Income / (Expense)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Interest Income
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Non-Interest Income
0.00 0.00 0.00 -6.44 0.00 0.00 0.00 - 0.00 0.00 0.00
Net Realized & Unrealized Capital Gains on Investments
0.00 0.00 0.00 -6.44 0.00 0.00 0.00 - 0.00 0.00 0.00
Total Non-Interest Expense
0.00 4.60 4.98 - 0.00 0.00 0.00 -7.17 0.00 0.00 0.00
Nonoperating Income / (Expense), net
4.35 -1.50 -8.22 -10 -13 -1.87 -9.83 -7.99 -31 -16 -3.58
Basic Earnings per Share
$0.63 $0.59 $0.64 $0.54 $0.45 $0.00 $0.00 $0.44 $0.42 $0.00 $0.00
Weighted Average Basic Shares Outstanding
37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.04M 36.92M 36.85M 36.85M
Diluted Earnings per Share
$0.63 $0.59 $0.64 $0.54 $0.45 $0.00 $0.00 $0.44 $0.42 $0.00 $0.00
Weighted Average Diluted Shares Outstanding
37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.04M 36.92M 36.85M 36.85M
Weighted Average Basic & Diluted Shares Outstanding
37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 36.99M 36.92M 36.85M 36.85M 36.85M

Annual Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
1.42 8.68 -6.46 7.40 15 -7.93
Net Cash From Operating Activities
-62 -158 28 92 59 75
Net Cash From Continuing Operating Activities
-62 -158 28 92 59 75
Net Income / (Loss) Continuing Operations
55 84 16 84 74 35
Consolidated Net Income / (Loss)
55 84 16 84 74 35
Amortization Expense
-3.78 -8.73 -5.12 -5.17 -6.46 -3.43
Non-Cash Adjustments to Reconcile Net Income
-114 -227 8.55 13 -10 49
Changes in Operating Assets and Liabilities, net
1.71 -5.35 8.97 0.66 2.50 -5.46
Net Cash From Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
63 166 -34 -85 -43 -83
Net Cash From Continuing Financing Activities
63 166 -34 -85 -43 -83
Issuance of Debt
402 790 339 548 347 512
Issuance of Common Equity
44 53 0.00 0.00 0.00 0.00
Repayment of Debt
-336 -629 -318 -565 -312 -525
Repurchase of Common Equity
-2.21 -0.52 0.00 0.00 0.00 -1.33
Payment of Dividends
-43 -48 -55 -65 -75 -68
Other Financing Activities, Net
-2.50 0.54 -0.22 -3.86 -3.43 -1.07
Effect of Exchange Rate Changes
0.00 0.01 -0.01 0.09 -0.49 -0.11
Cash Interest Paid
14 15 27 55 60 52
Cash Income Taxes Paid
0.69 2.18 1.97 0.67 1.34 1.60

Quarterly Cash Flow Statements for Crescent Capital BDC

This table details how cash moves in and out of Crescent Capital BDC's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
7.48 4.19 1.70 1.59 -8.89 -4.39 1.66 3.69 -4.90 9.15 0.46
Net Cash From Operating Activities
39 -25 47 -2.89 -15 36 31 23 -24 9.85 24
Net Cash From Continuing Operating Activities
39 -25 47 -2.89 -15 36 31 23 -24 9.85 24
Net Income / (Loss) Continuing Operations
28 20 15 9.99 3.90 15 7.10 8.49 -16 -3.25 10
Consolidated Net Income / (Loss)
28 20 15 9.99 3.90 15 7.10 8.49 -16 -3.25 10
Amortization Expense
-1.79 -1.55 -1.82 -1.31 -1.42 -0.51 -0.75 -0.75 -0.85 -0.25 -0.39
Non-Cash Adjustments to Reconcile Net Income
21 -44 26 -14 -16 33 19 13 7.43 -6.87 16
Changes in Operating Assets and Liabilities, net
-7.36 0.04 7.28 2.07 -1.47 -12 5.28 2.25 -15 20 -1.22
Net Cash From Financing Activities
-32 29 -45 4.97 6.34 -41 -29 -19 19 -0.61 -24
Net Cash From Continuing Financing Activities
-32 29 -45 4.97 6.34 -41 -29 -19 19 -0.61 -24
Issuance of Debt
60 125 55 107 258 69 82 104 349 274 52
Repayment of Debt
-73 -75 -82 -83 -233 -92 -93 -107 -312 -254 -62
Payment of Dividends
-19 -19 -19 -18 -17 -17 -17 -16 -16 -17 -14
Other Financing Activities, Net
0.00 -1.90 - -1.53 -1.07 - - - -1.48 -3.50 0.01
Effect of Exchange Rate Changes
-0.07 0.06 0.02 -0.49 -0.11 0.10 -0.05 -0.04 0.14 -0.09 -0.08
Cash Interest Paid
18 13 17 13 15 14 14 8.74 17 10 17

Annual Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,515 1,303 1,627 1,656 1,622
Cash and Due from Banks
- 6.40 7.78 10 5.04
Restricted Cash
- 11 17 29 26
Trading Account Securities
- 8.15 1,587 4.82 2.14
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00
Other Assets
2,515 1,268 1.46 1,600 19
Total Liabilities & Shareholders' Equity
0.00 1,303 1,627 1,656 1,622
Total Liabilities
0.00 690 885 916 916
Long-Term Debt
0.00 654 845 876 886
Other Long-Term Liabilities
0.00 18 21 21 30
Commitments & Contingencies
- 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.00 613 743 741 706
Total Preferred & Common Equity
0.00 613 743 741 706
Preferred Stock
- 0.00 0.00 0.00 0.00
Total Common Equity
0.00 613 743 741 706
Common Stock
- 675 966 959 957
Retained Earnings
- -62 -223 -218 -251

Quarterly Balance Sheets for Crescent Capital BDC

This table presents Crescent Capital BDC's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
1,625 1,624 1,620 1,672 1,645 1,666 1,654 1,628 1,618 1,619 1,601
Cash and Due from Banks
7.54 6.00 6.74 11 17 12 9.74 5.79 6.14 16 12
Restricted Cash
14 17 25 25 21 18 16 22 20 20 24
Trading Account Securities
7.07 8.85 4.71 2.77 1.40 4.24 1.44 2.08 1.81 1.26 0.34
Loans and Leases, Net of Allowance
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
1,584 28 21 23 1,595 1,623 26 1,583 31 15 14
Total Liabilities & Shareholders' Equity
1,625 1,624 1,620 1,672 1,645 1,666 1,654 1,628 1,618 1,619 1,601
Total Liabilities
899 894 869 920 896 939 930 914 944 962 949
Long-Term Debt
859 864 840 891 857 903 900 875 915 935 919
Other Long-Term Liabilities
23 30 29 29 21 21 30 23 28 27 30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
726 730 752 752 749 727 725 714 674 656 653
Total Preferred & Common Equity
726 730 752 752 749 727 725 714 674 656 653
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
726 730 752 752 749 727 725 714 674 656 653
Common Stock
788 788 966 966 966 959 959 959 956 955 955
Retained Earnings
-63 -58 -214 -213 -217 -232 -234 -245 -282 -299 -302

Annual Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
0.00 - - - - 36,992,523.00
DEI Adjusted Shares Outstanding
0.00 - - - - 36,992,523.00
DEI Earnings Per Adjusted Shares Outstanding
0.00 - - - - -0.88
Growth Metrics
- - - - - -
Revenue Growth
0.00% 638.18% -100.00% 0.00% 0.00% 0.00%
EBITDA Growth
0.00% 396.17% -107.29% -1.04% -25.05% 46.95%
EBIT Growth
0.00% 496.17% -100.00% 0.00% 0.00% 0.00%
NOPAT Growth
0.00% -21.30% -100.00% 0.00% 0.00% 0.00%
Net Income Growth
0.00% 44.39% -154.95% 100.61% -6,125.86% -104.49%
EPS Growth
0.00% -7.22% 15.57% 19.17% 4.35% -24.58%
Operating Cash Flow Growth
0.00% -155.11% 117.73% 230.21% -36.18% 26.85%
Free Cash Flow Firm Growth
0.00% 0.00% 151.23% -125.67% 90.92% 183.53%
Invested Capital Growth
0.00% 0.00% -49.63% 25.29% 1.83% -1.50%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 100.00% -100.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 93.35% -157.96% -117.99%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 100.00% -100.00% -100.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 100.00% -100.00% -100.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 100.36% -278.49% 0.24%
EPS Q/Q Growth
0.00% 0.00% 0.00% 4.07% -2.83% -5.24%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 121.89% -7.28% -38.89% 51.91%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 98.18% 32.50%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 6,612,903.38% 0.65% 0.17%
Profitability Metrics
- - - - - -
EBITDA Margin
0.00% 84.25% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 94.72% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 94.72% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
54.51% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
-503.37% 100.00% 0.00% 0.00% 0.00% 0.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 6.28% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 6.28% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 0.00% -14.16% 0.04% -2.14% -4.48%
Cash Return on Invested Capital (CROIC)
0.00% -193.72% 66.00% -22.45% -1.82% 1.52%
Operating Return on Assets (OROA)
0.00% 3.14% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 3.14% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% 0.00% -14.16% 0.04% -2.14% -4.48%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% -7.08% 0.04% -2.14% -4.59%
Net Operating Profit after Tax (NOPAT)
100 79 0.00 0.00 0.00 0.00
NOPAT Margin
0.00% 94.72% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 2.74% -0.04% 1.84% 3.68%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 5.28% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-20 79 0.00 0.00 0.00 0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-24 70 -5.12 -5.17 -6.46 -3.43
Valuation Ratios
- - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.51 0.78 0.96 0.71
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.51 0.78 0.96 0.71
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
0.00 0.00 0.00 2,192.89 0.00 0.00
Dividend Yield
16.48% 13.51% 17.55% 11.63% 10.61% 13.48%
Earnings Yield
0.00% 0.00% 0.00% 0.05% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.75 0.88 0.96 0.85
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 34.07 15.14 26.29 18.16
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.76 0.00 0.00 55.82
Leverage & Solvency
- - - - - -
Debt to Equity
0.00 0.00 1.07 1.14 1.18 1.26
Long-Term Debt to Equity
0.00 0.00 1.07 1.14 1.18 1.26
Financial Leverage
0.00 0.00 5.17 1.11 1.16 1.22
Leverage Ratio
0.00 0.00 6.23 2.16 2.21 2.27
Compound Leverage Factor
0.00 0.00 0.00 0.00 0.00 0.00
Debt to Total Capital
0.00% 0.00% 51.65% 53.22% 54.18% 55.66%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 51.65% 53.22% 54.18% 55.66%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 0.00% 48.35% 46.78% 45.82% 44.34%
Debt to EBITDA
0.00 0.00 -127.92 -163.43 -135.49 -258.42
Net Debt to EBITDA
0.00 0.00 -124.59 -158.70 -129.40 -249.24
Long-Term Debt to EBITDA
0.00 0.00 -127.92 -163.43 -135.49 -258.42
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -2,436 1,248 -320 -29 24
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
-3.99 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-3.99 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - -
Asset Turnover
0.00 0.03 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - -
Invested Capital
0.00 2,515 1,267 1,587 1,616 1,592
Invested Capital Turnover
0.00 0.07 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 2,515 -1,248 320 29 -24
Enterprise Value (EV)
0.00 0.00 952 1,397 1,549 1,357
Market Capitalization
0.00 0.00 315 577 712 502
Book Value per Share
$0.00 $0.00 $19.83 $20.04 $19.98 $19.09
Tangible Book Value per Share
$0.00 $0.00 $19.83 $20.04 $19.98 $19.09
Total Capital
0.00 0.00 1,267 1,587 1,616 1,592
Total Debt
0.00 0.00 654 845 876 886
Total Long-Term Debt
0.00 0.00 654 845 876 886
Net Debt
0.00 0.00 637 820 836 855
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
46 0.00 43 -0.26 16 32
Net Nonoperating Obligations (NNO)
0.00 2,515 654 845 876 886
Total Depreciation and Amortization (D&A)
-3.78 -8.73 -5.12 -5.17 -6.46 -3.43
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.93 $2.30 $2.40 $1.81
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 30.89M 35.93M 37.06M 37.04M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.93 $2.30 $2.40 $1.81
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 30.89M 35.93M 37.06M 37.04M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 30.89M 37.06M 37.06M 36.92M
Normalized Net Operating Profit after Tax (NOPAT)
70 55 0.00 0.00 0.00 0.00
Normalized NOPAT Margin
0.00% 66.31% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 94.72% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - -
EBIT to Interest Expense
-1.29 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
6.48 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
-1.29 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
6.48 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - -
Dividend Payout Ratio
77.98% 60.46% -127.45% 24,543.73% -474.73% -209.25%
Augmented Payout Ratio
82.02% 61.12% -127.45% 24,543.73% -474.73% -213.37%

Quarterly Metrics And Ratios for Crescent Capital BDC

This table displays calculated financial ratios and metrics derived from Crescent Capital BDC's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - 37,061,547.00 37,061,547.00 37,061,547.00 36,992,523.00 36,922,692.00 36,845,952.00 36,845,952.00
DEI Adjusted Shares Outstanding
- - - - 37,061,547.00 37,061,547.00 37,061,547.00 36,992,523.00 36,922,692.00 36,845,952.00 36,845,952.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.34 -0.15 -0.36 -0.02 -0.84 -0.44 -0.10
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Growth
-29.19% -93.38% 477.70% -340.34% 20.47% 33.52% 36.24% -22.44% 40.23% 50.68% 47.93%
EBIT Growth
0.00% 0.00% 0.00% 0.00% 0.00% 22.25% 27.93% -25.20% 0.00% 0.00% 0.00%
NOPAT Growth
0.00% 0.00% 0.00% 0.00% 0.00% 22.25% 27.93% -25.20% 0.00% 0.00% 0.00%
Net Income Growth
143.81% -206.09% -281.85% -316.93% -392.41% 10.64% -1.68% 8.75% -143.81% -761.53% 63.60%
EPS Growth
16.67% 5.36% 8.47% -11.48% -28.57% -22.03% -28.13% -18.52% -6.67% 0.00% 0.00%
Operating Cash Flow Growth
146.74% -221.14% 119.82% -108.35% -138.30% 247.90% -34.45% 883.87% -57.31% -72.97% -20.66%
Free Cash Flow Firm Growth
-5,489,327.66% -23,525,510.03% -6,671,974.99% 89.51% 97.60% 101.00% 100.88% 230.94% 206.13% 73.13% 5.39%
Invested Capital Growth
5,489,227.66% 23,525,610.03% 6,690,663.48% 1.83% 2.40% -1.15% -1.04% -1.50% -2.49% -2.01% -1.10%
Revenue Q/Q Growth
-100.00% 0.00% 529.82% -200.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
-129.59% -160.48% 251.67% -267.64% -117.19% -187.62% -5.94% 248.07% -113.25% 70.35% -54.37%
EBIT Q/Q Growth
-100.00% -100.00% 529.82% -200.00% -100.00% 0.00% -0.20% 299.80% -100.00% 0.00% 0.00%
NOPAT Q/Q Growth
-100.00% -100.00% 529.82% -200.00% -100.00% 0.00% -0.20% 299.80% -100.00% 0.00% 0.00%
Net Income Q/Q Growth
-44.26% 0.00% -18.28% -854.60% -1,308.31% 57.12% -145.97% 93.86% -3,662.74% 47.93% 77.84%
EPS Q/Q Growth
3.28% 0.00% 8.47% -15.63% -16.67% 2.22% 0.00% -4.35% -4.55% -100.00% 0.00%
Operating Cash Flow Q/Q Growth
14.14% 0.00% 290.52% -106.16% -423.64% 340.85% -15.56% -26.40% -205.09% 141.39% 147.86%
Free Cash Flow Firm Q/Q Growth
-20,467.03% -39,312.72% -144,797.96% 97.90% -70.67% 142.90% -13.73% 107.32% 38.33% -19.33% -46.36%
Invested Capital Q/Q Growth
26,530,182.33% 1,273,864.77% 603,676.02% 0.65% 0.84% -0.34% -2.16% 0.17% -0.17% 0.14% -1.25%
Profitability Metrics
- - - - - - - - - - -
EBITDA Margin
0.00% 0.00% 71.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Margin
0.00% 0.00% 100.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profit (Net Income) Margin
0.00% 0.00% -27.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent
0.00% 0.00% -27.52% 262.69% 0.00% 152.36% 374.04% -11.50% 0.00% 0.00% 0.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 1.58% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.11% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 0.00% 1.70% -2.14% -4.45% -4.37% -4.44% -4.48% -7.24% -9.41% -8.59%
Cash Return on Invested Capital (CROIC)
-99.09% 1.41% -99.45% -1.82% -2.37% 1.20% 1.15% 1.52% 2.52% 2.03% 1.11%
Operating Return on Assets (OROA)
0.00% 0.00% 2.20% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Assets (ROA)
0.00% 0.00% -0.60% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Common Equity (ROCE)
0.00% 0.00% 1.70% -2.14% -4.45% -4.37% -4.44% -4.48% -7.24% -9.41% -8.59%
Return on Equity Simple (ROE_SIMPLE)
1.93% 1.55% 1.19% 0.00% -4.53% -4.45% -4.55% 0.00% -7.52% -9.90% -8.99%
Net Operating Profit after Tax (NOPAT)
0.00 0.00 4.51 -4.51 0.00 -2.51 -2.51 5.02 0.00 0.00 0.00
NOPAT Margin
0.00% 0.00% 70.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-1.04% 0.34% 1.47% 1.44% 1.46% 0.33% 1.26% 0.66% 3.41% 1.76% 0.40%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
0.00 0.00 6.44 -6.44 0.00 -3.58 -3.59 7.17 0.00 0.00 0.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-1.79 -1.55 4.62 -7.75 -1.42 -4.09 -4.33 6.42 -0.85 -0.25 -0.39
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.78 0.00 0.89 0.96 0.77 0.72 0.74 0.71 0.67 0.61 0.52
Price to Tangible Book Value (P/TBV)
0.78 0.00 0.89 0.96 0.77 0.72 0.74 0.71 0.67 0.61 0.52
Price to Revenue (P/Rev)
2,242.77 0.00 37.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Earnings (P/E)
40.57 0.00 75.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
12.00% 11.39% 11.36% 10.61% 13.28% 13.76% 13.32% 13.48% 14.65% 14.93% 17.21%
Earnings Yield
2.46% 0.00% 1.33% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.88 0.00 0.93 0.96 0.88 0.86 0.87 0.85 0.84 0.82 0.78
Enterprise Value to Revenue (EV/Rev)
5,315.82 0.00 82.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 133.41 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
5,315.82 0.00 82.34 0.00 0.00 1,363.50 570.01 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
96.16 0.00 167.58 0.00 0.00 1,947.86 814.30 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
12.07 0.00 15.44 26.29 334.01 21.36 27.98 18.16 20.25 32.99 36.88
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 71.18 75.02 55.82 32.98 39.79 69.57
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.12 1.18 1.14 1.18 1.24 1.24 1.23 1.26 1.36 1.42 1.41
Long-Term Debt to Equity
1.12 1.18 1.14 1.18 1.24 1.24 1.23 1.26 1.36 1.42 1.41
Financial Leverage
1.12 1.18 1.14 1.16 1.18 1.21 1.18 1.22 1.30 1.33 1.31
Leverage Ratio
2.16 2.22 2.20 2.21 2.22 2.25 2.24 2.27 2.34 2.37 2.36
Compound Leverage Factor
0.00 0.00 -0.60 5.82 0.00 3.43 8.37 -0.26 0.00 0.00 0.00
Debt to Total Capital
52.78% 54.21% 53.38% 54.18% 55.39% 55.39% 55.07% 55.66% 57.60% 58.76% 58.46%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
52.78% 54.21% 53.38% 54.18% 55.39% 55.39% 55.07% 55.66% 57.60% 58.76% 58.46%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
47.22% 45.79% 46.62% 45.82% 44.61% 44.61% 44.93% 44.34% 42.40% 41.24% 41.54%
Debt to EBITDA
-158.22 167.92 76.86 -135.49 -148.07 -222.94 -556.46 -258.42 -320.44 -360.02 -410.23
Net Debt to EBITDA
-152.21 161.11 73.47 -129.40 -143.07 -216.47 -538.79 -249.24 -311.13 -346.27 -394.06
Long-Term Debt to EBITDA
-158.22 167.92 76.86 -135.49 -148.07 -222.94 -556.46 -258.42 -320.44 -360.02 -410.23
Debt to NOPAT
57.79 76.63 96.55 0.00 0.00 1,255.30 518.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
55.59 73.52 92.29 0.00 0.00 1,218.83 501.55 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
57.79 76.63 96.55 0.00 0.00 1,255.30 518.00 0.00 0.00 0.00 0.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,592 -1,643 -1,602 -34 -38 16 14 29 41 33 18
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,592 1,643 1,606 1,616 1,630 1,625 1,589 1,592 1,590 1,592 1,572
Invested Capital Turnover
0.00 0.01 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Increase / (Decrease) in Invested Capital
1,592 1,643 1,606 29 38 -19 -17 -24 -41 -33 -18
Enterprise Value (EV)
1,398 0.00 1,488 1,549 1,431 1,396 1,376 1,357 1,338 1,302 1,221
Market Capitalization
590 0.00 669 712 558 523 528 502 449 402 338
Book Value per Share
$20.28 $20.30 $20.20 $19.98 $19.62 $19.55 $19.27 $19.09 $18.26 $17.82 $17.72
Tangible Book Value per Share
$20.28 $20.30 $20.20 $19.98 $19.62 $19.55 $19.27 $19.09 $18.26 $17.82 $17.72
Total Capital
1,592 1,643 1,606 1,616 1,630 1,625 1,589 1,592 1,590 1,592 1,572
Total Debt
840 891 857 876 903 900 875 886 915 935 919
Total Long-Term Debt
840 891 857 876 903 900 875 886 915 935 919
Net Debt
808 855 819 836 872 874 848 855 889 900 883
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Nonoperating Expense (NNE)
-4.35 1.50 6.28 12 13 2.95 11 5.84 31 16 3.58
Net Nonoperating Obligations (NNO)
840 891 857 876 903 900 875 886 915 935 919
Total Depreciation and Amortization (D&A)
-1.79 -1.55 -1.82 -1.31 -1.42 -0.51 -0.75 -0.75 -0.85 -0.25 -0.39
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.63 $0.59 $0.64 $0.54 $0.45 $0.46 $0.46 $0.44 $0.42 $0.00 $0.00
Adjusted Weighted Average Basic Shares Outstanding
37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.04M 36.92M 36.85M 36.85M
Adjusted Diluted Earnings per Share
$0.63 $0.59 $0.64 $0.54 $0.45 $0.46 $0.46 $0.44 $0.42 $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding
37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 37.04M 36.92M 36.85M 36.85M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
37.06M 37.06M 37.06M 37.06M 37.06M 37.06M 36.99M 36.92M 36.85M 36.85M 36.85M
Normalized Net Operating Profit after Tax (NOPAT)
0.00 0.00 4.51 -4.51 0.00 -2.51 -2.51 5.02 0.00 0.00 0.00
Normalized NOPAT Margin
0.00% 0.00% 70.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Pre Tax Income Margin
0.00% 0.00% -27.52% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
486.88% 643.88% 851.51% -474.73% -224.08% -222.84% -216.73% -209.25% -130.03% -100.26% -104.50%
Augmented Payout Ratio
486.88% 643.88% 851.51% -474.73% -224.08% -222.84% -217.76% -213.37% -134.64% -104.88% -109.04%

Financials Breakdown Chart

Key Financial Trends

Crescent Capital BDC’s (NASDAQ:CCAP) financial data shows a mixed trend: the company has maintained a sizable asset base and continued paying dividends, but recent earnings have weakened, equity has declined, and leverage has increased. The income statement also contains several zero or inconsistent standardized fields, so investors should rely on the company’s filed reports for detailed net investment income and earnings analysis.

  • Cash generation improved in the second quarter of 2026. Net cash from operating activities was $9.8 million, reversing the $23.8 million operating cash outflow in the first quarter. This was supported by a $20.2 million favorable change in operating assets and liabilities.
  • Cash balances increased sequentially. Cash and due from banks rose from $6.1 million in Q1 2026 to $15.6 million in Q2, while total cash and restricted cash remained approximately $35.7 million.
  • The company continues to support regular shareholder distributions. Quarterly dividend payments remained substantial, ranging from approximately $15.5 million to $19.3 million across the reported periods, including $16.6 million in Q2 2026.
  • Debt refinancing activity appears active rather than purely additive. In Q2 2026, CCAP issued $273.8 million of debt and repaid $253.6 million, producing a relatively modest $20.2 million net increase. This follows a net debt increase of approximately $36.8 million in Q1 2026.
  • Total assets have remained relatively stable. Assets were $1.62 billion in Q2 2026, compared with $1.63 billion in Q3 2023 and $1.67 billion in Q1 2025. This suggests the balance sheet has not experienced a sharp contraction despite recent earnings volatility.
  • Portfolio-related assets are difficult to interpret from the standardized data. “Other assets” represented approximately $1.51 billion in Q2 2026, while net loans and leases were reported as zero. This likely reflects classification limitations in the supplied data rather than an absence of investments, and investors should review CCAP’s portfolio schedule and fair-value disclosures.
  • Reported results have been affected by restatements and data inconsistencies. Several 2023–2025 income and cash-flow periods are marked as restated, and the standardized income statement reports zero for interest income, interest expense, total revenue, and EPS in some periods despite nonzero net income or loss figures. These fields should not be treated as a complete operating-performance history.
  • Net losses have become more frequent and larger. The company reported net losses of $31.0 million in Q1 2026 and $16.1 million in Q2 2026, compared with a $0.8 million loss in Q4 2025 and positive net income in several earlier periods. The Q2 loss was an improvement from Q1 but remained significant.
  • Equity has declined materially from prior levels. Total common equity fell to $656.5 million in Q2 2026 from $714.1 million in Q3 2025, $724.7 million in Q2 2025, and $748.8 million in Q3 2024. Retained earnings were negative $298.9 million in Q2 2026, indicating cumulative pressure from losses and distributions.
  • Leverage has increased relative to equity. Long-term debt rose to $935.3 million in Q2 2026 from $875.3 million in Q3 2025, while equity declined. Debt was approximately 1.42 times common equity in Q2 2026, versus roughly 1.23 times in Q3 2025, increasing financial risk if portfolio valuations or cash earnings weaken.

Overall, CCAP’s second-quarter cash flow improved and liquidity increased, but those positives were accompanied by continued net losses, falling equity, and higher leverage. The key issues for investors are whether operating earnings can recover sufficiently to support recurring dividends and whether the company can stabilize or reduce debt without shrinking its investment portfolio.

11/17/26 04:13 PM ETAI Generated. May Contain Errors.

Crescent Capital BDC Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Crescent Capital BDC's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Crescent Capital BDC's net income appears to be on a downward trend, with a most recent value of -$32.41 million in 2025, compared with $54.67 million in 2020. The previous period was -$15.85 million in 2024. Find out what analysts predict for Crescent Capital BDC in the coming months.

Over the last 5 years, Crescent Capital BDC's total revenue changed from -$15.49 million in 2020 to $0.00 in 2025.

In the past 13 quarters, Crescent Capital BDC's cash and equivalents has ranged from $5.79 million in Q3 2025 to $17.09 million in Q3 2024, and is currently $12.08 million as of their latest financial filing in Q3 2026.

Crescent Capital BDC had total debt of $886.13 million at the end of 2025, a 1.2% increase from 2024, and none in 2020.

Over the last 5 years, Crescent Capital BDC's book value per share changed from 0.00 in 2020 to 19.09 in 2025, a change of 1,908.6%.



Financial statements for NASDAQ:CCAP last updated on 11/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners